Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
Kiem Oen, Lori Tucker, Adam M Huber...
https://pubmed.ncbi.nlm.nih.gov/19644903/Actively Recruiting
Led by University of British Columbia · Updated on 2025-06-25
1238
Participants Needed
15
Research Sites
N/A
Total Duration
Juvenile Idiopathic Arthritis JIA is a chronic inflammatory condition affecting children and characterized by joint and organ inflammation. This ongoing national registry study collects detailed information on Canadian children newly diagnosed with JIA to better understand the diseases course, outcomes, and medication side effects. The study aims to improve healthcare decisions and provide new insights into managing JIA through collaboration among pediatric rheumatologists across Canada. The registry collects data from both physicians and families at regular clinic visits without requiring extra visits solely for the study. Information is gathered through online or paper forms, including clinical data and patient-reported outcomes, with privacy protections in place. The registry supports quality control, data monitoring, and annual reporting, enabling comparisons of treatments and outcomes across Canada and with other countries. Participants contribute data from diagnosis onward, with ongoing follow-up visits to track disease activity, pain, quality of life, and disability over time. The main measure is the proportion of children achieving inactive disease at one year. The study also collects secondary outcomes like disease activity scores and functional assessments. Data access is carefully managed, and results are shared with families, researchers, and healthcare organizations to support improved care and research.
CONDITIONS
CAPRI National Juvenile Idiopathic Arthritis Registry
J
Jaime Guzman, MD, FRCPC
M
Martha Sieres
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of British Columbia
Lead Sponsor
Children's Hospital of Eastern Ontario
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
At the medical visit where a new diagnosis of Juvenile Idiopathic Arthritis is made
Duration - Ongoing after enrollment, with yearly updates close to diagnosis anniversary
Participants who have been newly diagnosed or are part of existing cohorts are observed through their routine clinic visits where data about their disease course, outcomes, and medication adverse events are collected.
Data collected at every subsequent clinic visit and additional yearly visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Kiem Oen, Lori Tucker, Adam M Huber...
https://pubmed.ncbi.nlm.nih.gov/19644903/Timothy Beukelman, Nivedita M Patkar, Kenneth G Saag...
https://pubmed.ncbi.nlm.nih.gov/21452260/Jaime Guzman, Kiem Oen, Lori B Tucker...
https://pubmed.ncbi.nlm.nih.gov/24842571/Natalie J Shiff, Lori B Tucker, Jaime Guzman...
https://pubmed.ncbi.nlm.nih.gov/20716664/A Ravelli, A Martini
https://pubmed.ncbi.nlm.nih.gov/14969057/Kiem Oen, Ciarán M Duffy, Shirley M L Tse...
https://pubmed.ncbi.nlm.nih.gov/20391508/Ross E Petty, Taunton R Southwood, Prudence Manners...
https://pubmed.ncbi.nlm.nih.gov/14760812/Natalie Jane Shiff, Lisa M Lix, Kiem Oen...
https://pubmed.ncbi.nlm.nih.gov/25023756/Jaime Guzman, Kiem Oen, Adam M Huber...
https://pubmed.ncbi.nlm.nih.gov/25985972/N Adib, A Silman, W Thomson
https://pubmed.ncbi.nlm.nih.gov/15827045/University of British Columbia
Lead Sponsor
Children's Hospital of Eastern Ontario
Collaborating Sponsor